Other

The University of British Columbia

Albert F Burton

David I McLean

Hugh J Freeman

Stephen Gislason

This invention relates to the novel use of N-acetyl glucosamine for the treatment of gastrointestinal tract disorders by restoring and maintaining the integrity and normal function of the gastrointestinal tract. A method of treating gastrointestinal mucous membrane disorder in a human being comprising feeding the human being a therapeutic amount of N-acetyl glucosamine on a periodic basis.

Method for treatment of lower gastrointestinal tract disorders

This invention pertains to the novel use of N-acetyl glucosamine as a cytoprotective agent for persons afflicted with psoriasis by restoring integrity and normal function of skin. A method of treating psoriasis in a human being comprising feeding the human being a therapeutic amount of N-acetyl glucosamine, or a pharmaceutically acceptable salt thereof, on a periodic basis.

Method and composition for treating psoriasis

This invention pertains to the novel use of N-acetyl glucosamine to minimize or eliminate food intolerance or food allergy symptoms in human beings afflicted with these symptoms by maintaining the integrity and normal function of the gastrointestinal tract in such human beings. A method of alleviating food sensitivity and food allergy in a human being comprising feeding the human being a therapeutic amount of N-acetyl glucosamine on a periodic basis.

Method and composition for treatment of food allergy

This invention pertains to the use of medium chain fatty acids (C8-10) in the treatment of skin lesions. More particularly, the invention relates to a preparation containing medium chain fatty acids (C8-10) which has beneficial effects when applied topically in skin conditions, including acne, psoriasis, chronic conditions considered to be pre-cancerous lesions, and malignant lesions of skin. A composition for topically treating skin lesions which comprises a fatty acid of a carbon number from 8 to 10 having a free carboxyl group and a pharmaceutically acceptable carrier.

Growing community of inventors

Vancouver, Canada

Albert F Burton